December 10-13, 2022 | New Orleans, LA
NEWS
One company’s failed drug is this company’s ‘jewel’
Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology
December 10-13, 2022 | New Orleans, LA
October 14 - 15, 2022 | New York, NY
June 13 - 16, 2022 | San Diego, CA